DXCM vs XPER · P/E 63, rev $2.50B vs rev $448.1M
DexCom Inc (DXCM) versus Xperi Corp (XPER) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Xperi Corp (XPER) is a software - application company listed on US.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported XPER revenue for 2025-12-31 was $448.1M. Net income was -$56.3M. Revenue was down 9.2% from 2024-12-31 to 2025-12-31. XPER currently screens at market cap $367.8M.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. XPER currently screens at market cap $367.8M.
Not investment advice. Open the DXCM and XPER stock pages for the full models.
Not investment advice.